{
    "2020-02-26": [
        [
            {
                "time": "2020-02-26",
                "original_text": "复星医药：国内首个CAR-T报产 卖亏损资产提业绩 投资失误",
                "features": {
                    "keywords": [
                        "复星医药",
                        "CAR-T",
                        "亏损资产",
                        "投资失误"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-02-26",
                "original_text": "复星医药(02196)拟为复星实业不超过1.27亿美元授信项下债务提供担保 大额借贷担保",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复星实业",
                        "担保",
                        "大额借贷"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-02-26",
                "original_text": "复星医药：为控股子公司提供1.27亿美元担保 大额借贷担保",
                "features": {
                    "keywords": [
                        "复星医药",
                        "控股子公司",
                        "担保",
                        "大额借贷"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-02-26",
                "original_text": "【关注】厉害了复星！3个新品、1款创新药将获批",
                "features": {
                    "keywords": [
                        "复星医药",
                        "新品",
                        "创新药",
                        "获批"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-02-26",
                "original_text": "复星医药：“17复药01”回售金额预计不超过1.58亿元",
                "features": {
                    "keywords": [
                        "复星医药",
                        "回售",
                        "债券"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-02-26",
                "original_text": "70股获券商买入评级 正邦科技目标涨幅达56.54%",
                "features": {
                    "keywords": [
                        "券商评级",
                        "正邦科技",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "农业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-02-26",
                "original_text": "A股再现深V走势 科技题材成反弹主力",
                "features": {
                    "keywords": [
                        "A股",
                        "深V走势",
                        "科技题材",
                        "反弹"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}